<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A mathematical model simulating <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> based on the two-hit theory of <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> is presented by contrasting the biologic variables responsible for a high risk of developing Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) in three immunosuppressed groups with that of nonendemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this model, the pro-B lymphocyte is considered to be the target for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-specific translocations such as t(8;14) </plain></SENT>
<SENT sid="2" pm="."><plain>With repeated mitosis, the target cell pool expands in the high-risk individual, and, thereby, the opportunities for a spontaneous translocation to arise are increased </plain></SENT>
<SENT sid="3" pm="."><plain>The chromosomal translocation endows the target cell with survival advantages, and, hence, <z:hpo ids='HP_0002665'>lymphoma</z:hpo> develops </plain></SENT>
<SENT sid="4" pm="."><plain>Modeling results demonstrate that this <z:mp ids='MP_0000351'>increased cell proliferation</z:mp> is sufficient in accounting entirely for the increase in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> prevalence </plain></SENT>
<SENT sid="5" pm="."><plain>Preventing enhanced cellular proliferation by obviating <z:hpo ids='HP_0002721'>immune deficiency</z:hpo> and treating patients with agents that restore immunity or have antiviral and antiproliferative properties prior to conversion from polyclonal B-cell proliferation to monoclonal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> could obviate the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
</text></document>